97 related articles for article (PubMed ID: 22209020)
1. High YKL-40 levels predict mortality in patients with type 2 diabetes.
Persson F; Rathcke CN; Gall MA; Parving HH; Vestergaard H; Rossing P
Diabetes Res Clin Pract; 2012 Apr; 96(1):84-9. PubMed ID: 22209020
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 levels are independently associated with albuminuria in type 2 diabetes.
Røndbjerg AK; Omerovic E; Vestergaard H
Cardiovasc Diabetol; 2011 Jun; 10():54. PubMed ID: 21696606
[TBL] [Abstract][Full Text] [Related]
3. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
[TBL] [Abstract][Full Text] [Related]
4. Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes.
Lin CH; Li HY; Jiang YD; Chang TJ; Chuang LM
Clin Endocrinol (Oxf); 2013 Aug; 79(2):185-91. PubMed ID: 22901243
[TBL] [Abstract][Full Text] [Related]
5. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.
Rathcke CN; Raymond I; Kistorp C; Hildebrandt P; Faber J; Vestergaard H
Int J Cardiol; 2010 Aug; 143(1):35-42. PubMed ID: 19223085
[TBL] [Abstract][Full Text] [Related]
6. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
7. YKL-40 in type 2 diabetic patients with different levels of albuminuria.
Brix JM; Höllerl F; Koppensteiner R; Schernthaner G; Schernthaner GH
Eur J Clin Invest; 2011 Jun; 41(6):589-96. PubMed ID: 21158852
[TBL] [Abstract][Full Text] [Related]
8. Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes.
Thomsen SB; Gjesing AP; Rathcke CN; Ekstrøm CT; Eiberg H; Hansen T; Pedersen O; Vestergaard H
PLoS One; 2015; 10(7):e0133672. PubMed ID: 26197239
[TBL] [Abstract][Full Text] [Related]
9. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients.
Lee JH; Kim SS; Kim IJ; Song SH; Kim YK; In Kim J; Jeon YK; Kim BH; Kwak IS
J Diabetes Complications; 2012; 26(4):308-12. PubMed ID: 22705282
[TBL] [Abstract][Full Text] [Related]
11. YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients.
Yasuda T; Kaneto H; Katakami N; Kuroda A; Matsuoka TA; Yamasaki Y; Matsuhisa M; Shimomura I
Diabetes Res Clin Pract; 2011 Feb; 91(2):e50-2. PubMed ID: 21159401
[TBL] [Abstract][Full Text] [Related]
12. Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2.
Żurawska-Płaksej E; Ługowska A; Hetmańczyk K; Knapik-Kordecka M; Adamiec R; Piwowar A
Biomarkers; 2015 Feb; 20(1):52-7. PubMed ID: 25519006
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
[TBL] [Abstract][Full Text] [Related]
14. YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes.
Batinic K; Höbaus C; Grujicic M; Steffan A; Jelic F; Lorant D; Hörtenhuber T; Hoellerl F; Brix JM; Schernthaner G; Koppensteiner R; Schernthaner GH
Atherosclerosis; 2012 Jun; 222(2):557-63. PubMed ID: 22572101
[TBL] [Abstract][Full Text] [Related]
15. Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus.
Sakamoto F; Katakami N; Kaneto H; Yasuda T; Takahara M; Miyashita K; Kuroda A; Matsuhisa M; Kosugi K; Shimomura I
Endocr J; 2013; 60(1):73-9. PubMed ID: 22986489
[TBL] [Abstract][Full Text] [Related]
16. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
[TBL] [Abstract][Full Text] [Related]
17. Correlation between serum YKL-40 levels and albuminuria in type 2 diabetes.
Han JY; Ma XY; Yu LJ; Shao Y; Wang QY
Genet Mol Res; 2015 Dec; 14(4):18596-603. PubMed ID: 26782508
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D levels and mortality in type 2 diabetes.
Joergensen C; Gall MA; Schmedes A; Tarnow L; Parving HH; Rossing P
Diabetes Care; 2010 Oct; 33(10):2238-43. PubMed ID: 20606205
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.
Mygind ND; Iversen K; Køber L; Goetze JP; Nielsen H; Boesgaard S; Bay M; Johansen JS; Nielsen OW; Kirk V; Kastrup J
J Intern Med; 2013 Feb; 273(2):205-16. PubMed ID: 23140269
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40 levels are associated with type 2 diabetes mellitus in patients with obstructive sleep apnea syndrome.
Sun L; Liu JY; Li LR
Genet Mol Res; 2015 Aug; 14(3):8919-25. PubMed ID: 26345823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
